TY - JOUR AU - Eckardt, K. U. AU - Coresh, J. AU - Devuyst, O. AU - Johnson, R. J. AU - Kottgen, A. AU - Levey, A. S. PY - 2013 DA - 2013// TI - Evolving importance of kidney disease: from subspecialty to global health burden JO - Lancet VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)60439-0 DO - 10.1016/S0140-6736(13)60439-0 ID - Eckardt2013 ER - TY - STD TI - Disease K. Improving global outcomes CKDMBDWG: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;S1–130. ID - ref2 ER - TY - JOUR AU - Levin, A. AU - Hemmelgarn, B. AU - Culleton, B. AU - Tobe, S. AU - McFarlane, P. AU - Ruzicka, M. PY - 2008 DA - 2008// TI - Guidelines for the management of chronic kidney disease JO - CMAJ VL - 179 UR - https://doi.org/10.1503/cmaj.080351 DO - 10.1503/cmaj.080351 ID - Levin2008 ER - TY - JOUR AU - Fraser, W. D. PY - 2009 DA - 2009// TI - Hyperparathyroidism JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)60507-9 DO - 10.1016/S0140-6736(09)60507-9 ID - Fraser2009 ER - TY - JOUR AU - Garside, R. AU - Pitt, M. AU - Anderson, R. AU - Mealing, S. AU - Roome, C. AU - Snaith, A. PY - 2007 DA - 2007// TI - The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation JO - Health Technol Assess VL - 11 ID - Garside2007 ER - TY - JOUR AU - Michels, T. C. AU - Kelly, K. M. PY - 2013 DA - 2013// TI - Parathyroid disorders JO - Am Fam Physician VL - 88 ID - Michels2013 ER - TY - JOUR AU - Cengiz, K. AU - Ozkan, A. PY - 1998 DA - 1998// TI - Depression and secondary hyperparathyroidism in chronic renal failure JO - Nephron VL - 79 UR - https://doi.org/10.1159/000045115 DO - 10.1159/000045115 ID - Cengiz1998 ER - TY - JOUR AU - Chertow, G. M. AU - Lu, Z. J. AU - Xu, X. AU - Knight, T. G. AU - Goodman, W. G. AU - Bushinsky, D. A. PY - 2012 DA - 2012// TI - Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols JO - Hemodial Int VL - 16 UR - https://doi.org/10.1111/j.1542-4758.2011.00642.x DO - 10.1111/j.1542-4758.2011.00642.x ID - Chertow2012 ER - TY - JOUR AU - Cunningham, J. AU - Danese, M. AU - Olson, K. AU - Klassen, P. AU - Chertow, G. M. PY - 2005 DA - 2005// TI - Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism JO - Kidney Int VL - 68 UR - https://doi.org/10.1111/j.1523-1755.2005.00596.x DO - 10.1111/j.1523-1755.2005.00596.x ID - Cunningham2005 ER - TY - JOUR AU - Cunningham, J. AU - Floege, J. AU - London, G. AU - Rodriguez, M. AU - Shanahan, C. M. PY - 2008 DA - 2008// TI - Clinical outcomes in secondary hyperparathyroidism and the potential role of calcimimetics JO - NDT Plus VL - 1 ID - Cunningham2008 ER - TY - JOUR AU - Curtin, R. B. AU - Bultman, D. C. AU - Thomas-Hawkins, C. AU - Walters, B. A. AU - Schatell, D. PY - 2002 DA - 2002// TI - Hemodialysis patients' symptom experiences: effects on physical and mental functioning JO - Nephrol Nurs J VL - 29 ID - Curtin2002 ER - TY - JOUR AU - Schumock, G. T. AU - Andress, D. L. AU - Marx, S. E. AU - Sterz, R. AU - Joyce, A. T. AU - Kalantar-Zadeh, K. PY - 2009 DA - 2009// TI - Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients JO - Nephron Clin Pract VL - 113 UR - https://doi.org/10.1159/000228076 DO - 10.1159/000228076 ID - Schumock2009 ER - TY - JOUR AU - Joy, M. S. AU - Karagiannis, P. C. AU - Peyerl, F. W. PY - 2007 DA - 2007// TI - Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment JO - J Manag Care Pharm VL - 13 ID - Joy2007 ER - TY - JOUR AU - Block, G. A. AU - Klassen, P. S. AU - Lazarus, J. M. AU - Ofsthun, N. AU - Lowrie, E. G. AU - Chertow, G. M. PY - 2004 DA - 2004// TI - Mineral metabolism, mortality, and morbidity in maintenance hemodialysis JO - J Am Soc Nephrol VL - 15 UR - https://doi.org/10.1097/01.ASN.0000133041.27682.A2 DO - 10.1097/01.ASN.0000133041.27682.A2 ID - Block2004 ER - TY - JOUR AU - Kovesdy, C. P. AU - Ahmadzadeh, S. AU - Anderson, J. E. AU - Kalantar-Zadeh, K. PY - 2008 DA - 2008// TI - Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease JO - Kidney Int VL - 73 UR - https://doi.org/10.1038/ki.2008.64 DO - 10.1038/ki.2008.64 ID - Kovesdy2008 ER - TY - JOUR AU - Bhuriya, R. AU - Li, S. AU - Chen, S. C. AU - McCullough, P. A. AU - Bakris, G. L. PY - 2009 DA - 2009// TI - Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP) JO - Am J Kidney Dis VL - 53 UR - https://doi.org/10.1053/j.ajkd.2008.11.029 DO - 10.1053/j.ajkd.2008.11.029 ID - Bhuriya2009 ER - TY - JOUR AU - Block, G. A. AU - Raggi, P. AU - Bellasi, A. AU - Kooienga, L. AU - Spiegel, D. M. PY - 2007 DA - 2007// TI - Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients JO - Kidney Int VL - 71 UR - https://doi.org/10.1038/sj.ki.5002059 DO - 10.1038/sj.ki.5002059 ID - Block2007 ER - TY - JOUR AU - Covic, A. AU - Kothawala, P. AU - Bernal, M. AU - Robbins, S. AU - Chalian, A. AU - Goldsmith, D. PY - 2009 DA - 2009// TI - Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease JO - Nephrol Dial Transplant VL - 24 UR - https://doi.org/10.1093/ndt/gfn613 DO - 10.1093/ndt/gfn613 ID - Covic2009 ER - TY - JOUR AU - Gansevoort, R. T. AU - Correa-Rotter, R. AU - Hemmelgarn, B. R. AU - Jafar, T. H. AU - Heerspink, H. J. AU - Mann, J. F. PY - 2013 DA - 2013// TI - Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention JO - Lancet VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)60595-4 DO - 10.1016/S0140-6736(13)60595-4 ID - Gansevoort2013 ER - TY - JOUR AU - Go, A. S. AU - Chertow, G. M. AU - Fan, D. AU - McCulloch, C. E. AU - Hsu, C. Y. PY - 2004 DA - 2004// TI - Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa041031 DO - 10.1056/NEJMoa041031 ID - Go2004 ER - TY - JOUR AU - Shantouf, R. S. AU - Budoff, M. J. AU - Ahmadi, N. AU - Ghaffari, A. AU - Flores, F. AU - Gopal, A. PY - 2010 DA - 2010// TI - Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients JO - Am J Nephrol VL - 31 UR - https://doi.org/10.1159/000294405 DO - 10.1159/000294405 ID - Shantouf2010 ER - TY - JOUR AU - Danese, M. D. AU - Belozeroff, V. AU - Smirnakis, K. AU - Rothman, K. J. PY - 2008 DA - 2008// TI - Consistent control of mineral and bone disorder in incident hemodialysis patients JO - Clin J Am Soc Nephrol VL - 3 UR - https://doi.org/10.2215/CJN.01060308 DO - 10.2215/CJN.01060308 ID - Danese2008 ER - TY - JOUR AU - Blayney, M. J. AU - Tentori, F. PY - 2009 DA - 2009// TI - Trends and consequences of mineral bone disorder in haemodialysis patients: lessons from The Dialysis Outcomes and Practice Patterns Study (DOPPS) JO - J Ren Care VL - 35 UR - https://doi.org/10.1111/j.1755-6686.2009.00048.x DO - 10.1111/j.1755-6686.2009.00048.x ID - Blayney2009 ER - TY - JOUR AU - Jadoul, M. AU - Albert, J. M. AU - Akiba, T. AU - Akizawa, T. AU - Arab, L. AU - Bragg-Gresham, J. L. PY - 2006 DA - 2006// TI - Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study JO - Kidney Int VL - 70 UR - https://doi.org/10.1038/sj.ki.5001754 DO - 10.1038/sj.ki.5001754 ID - Jadoul2006 ER - TY - JOUR AU - Block, G. A. AU - Martin, K. J. AU - Francisco, A. L. AU - Turner, S. A. AU - Avram, M. M. AU - Suranyi, M. G. PY - 2004 DA - 2004// TI - Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa031633 DO - 10.1056/NEJMoa031633 ID - Block2004 ER - TY - JOUR AU - Goodman, W. G. PY - 2004 DA - 2004// TI - The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease JO - Semin Dial VL - 17 UR - https://doi.org/10.1111/j.0894-0959.2004.17308.x DO - 10.1111/j.0894-0959.2004.17308.x ID - Goodman2004 ER - TY - JOUR AU - Michael, M. AU - Garcia, D. PY - 2004 DA - 2004// TI - Secondary hyperparathyroidism in chronic kidney disease: clinical consequences and challenges JO - Nephrol Nurs J VL - 31 ID - Michael2004 ER - TY - STD TI - National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003, 42:S1-201. ID - ref28 ER - TY - JOUR AU - Pasieka, J. L. AU - Parsons, L. L. PY - 2000 DA - 2000// TI - A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism JO - Surgery VL - 128 UR - https://doi.org/10.1067/msy.2000.108117 DO - 10.1067/msy.2000.108117 ID - Pasieka2000 ER - TY - JOUR AU - Boer, R. AU - Lalla, A. M. AU - Belozeroff, V. PY - 2012 DA - 2012// TI - Cost-effectiveness of cinacalcet in secondary hyperparathyroidism in the United States JO - J Med Econ VL - 15 UR - https://doi.org/10.3111/13696998.2012.664799 DO - 10.3111/13696998.2012.664799 ID - Boer2012 ER - TY - JOUR AU - Garside, R. AU - Pitt, M. AU - Anderson, R. AU - Mealing, S. AU - D'Souza, R. AU - Stein, K. PY - 2007 DA - 2007// TI - The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective JO - Nephrol Dial Transplant VL - 22 UR - https://doi.org/10.1093/ndt/gfl774 DO - 10.1093/ndt/gfl774 ID - Garside2007 ER - TY - JOUR AU - Iannazzo, S. AU - Carsi, M. AU - Chiroli, S. PY - 2012 DA - 2012// TI - A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five European countries JO - Appl Health Econ Health Policy VL - 10 UR - https://doi.org/10.2165/11597980-000000000-00000 DO - 10.2165/11597980-000000000-00000 ID - Iannazzo2012 ER - TY - JOUR AU - Komaba, H. AU - Moriwaki, K. AU - Goto, S. AU - Yamada, S. AU - Taniguchi, M. AU - Kakuta, T. PY - 2012 DA - 2012// TI - Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan JO - Am J Kidney Dis VL - 60 UR - https://doi.org/10.1053/j.ajkd.2011.12.034 DO - 10.1053/j.ajkd.2011.12.034 ID - Komaba2012 ER - TY - CHAP AU - Feeny, D. ED - Fayers, P. ED - Hays, R. PY - 2005 DA - 2005// TI - Preference-based measures: utility and quality-adjusted life years BT - Assessing quality of life in clinical trials 2nd edition PB - Oxford University Press CY - New York ID - Feeny2005 ER - TY - CHAP AU - Rowen, D. AU - Brazier, J. ED - Glied, S. ED - Smith, P. PY - 2011 DA - 2011// TI - Health Utility Measurement BT - The Oxford Handbook of Health Economics PB - Oxford University Press CY - New York ID - Rowen2011 ER - TY - JOUR AU - Liem, Y. S. AU - Bosch, J. L. AU - Hunink, M. G. PY - 2008 DA - 2008// TI - Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis JO - Value Health VL - 11 UR - https://doi.org/10.1111/j.1524-4733.2007.00308.x DO - 10.1111/j.1524-4733.2007.00308.x ID - Liem2008 ER - TY - JOUR AU - Wyld, M. AU - Morton, R. L. AU - Hayen, A. AU - Howard, K. AU - Webster, A. C. PY - 2012 DA - 2012// TI - A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments JO - PLoS Med VL - 9 UR - https://doi.org/10.1371/journal.pmed.1001307 DO - 10.1371/journal.pmed.1001307 ID - Wyld2012 ER - TY - JOUR AU - Eandi, M. AU - Pradelli, L. AU - Iannazzo, S. AU - Chiroli, S. AU - Pontoriero, G. PY - 2010 DA - 2010// TI - Economic evaluation of cinacalcet in the treatment of secondary hyperparathyroidism in Italy JO - Pharmacoeconomics VL - 28 UR - https://doi.org/10.2165/11538600-000000000-00000 DO - 10.2165/11538600-000000000-00000 ID - Eandi2010 ER - TY - STD TI - National Kidney Foundation [https://www.kidney.org/atoz/atozTopic_Transplantation.cfm] UR - https://www.kidney.org/atoz/atozTopic_Transplantation.cfm ID - ref39 ER - TY - STD TI - American Heart Association (AHA). Cardiovascular conditions. [http://www.heart.org/HEARTORG/Conditions/Conditions_UCM_001087_SubHomePage.jsp] Accessed January 16, 2014. UR - http://www.heart.org/HEARTORG/Conditions/Conditions_UCM_001087_SubHomePage.jsp ID - ref40 ER - TY - JOUR AU - Alpert, J. S. AU - Thygesen, K. AU - Antman, E. AU - Bassand, J. P. PY - 2000 DA - 2000// TI - Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction JO - J Am Coll Cardiol VL - 36 UR - https://doi.org/10.1016/S0735-1097(00)00804-4 DO - 10.1016/S0735-1097(00)00804-4 ID - Alpert2000 ER - TY - STD TI - American Stroke Association. Effects of stroke. [http://www.strokeassociation.org/STROKEORG/AboutStroke/EffectsofStroke/Effects-of-Stroke_UCM_308534_SubHomePage.jsp] Accessed January 16, 2014. UR - http://www.strokeassociation.org/STROKEORG/AboutStroke/EffectsofStroke/Effects-of-Stroke_UCM_308534_SubHomePage.jsp ID - ref42 ER - TY - JOUR AU - Tendera, M. AU - Aboyans, V. AU - Bartelink, M. L. AU - Baumgartner, I. AU - Clement, D. PY - 2011 DA - 2011// TI - ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC) JO - Eur Heart J VL - 32 UR - https://doi.org/10.1093/eurheartj/ehr211 DO - 10.1093/eurheartj/ehr211 ID - Tendera2011 ER - TY - JOUR AU - Hamm, C. W. AU - Bassand, J. P. AU - Agewall, S. AU - Bax, J. AU - Boersma, E. AU - Bueno, H. PY - 2011 DA - 2011// TI - ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) JO - Eur Heart J VL - 32 UR - https://doi.org/10.1093/eurheartj/ehr236 DO - 10.1093/eurheartj/ehr236 ID - Hamm2011 ER - TY - JOUR AU - McMurray, J. J. AU - Adamopoulos, S. AU - Anker, S. D. AU - Auricchio, A. AU - Bohm, M. AU - Dickstein, K. PY - 2012 DA - 2012// TI - ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC JO - Eur J Heart Fail VL - 14 UR - https://doi.org/10.1093/eurjhf/hfs033 DO - 10.1093/eurjhf/hfs033 ID - McMurray2012 ER - TY - BOOK PY - 2012 DA - 2012// TI - Lower limb peripheral arterial disease: diagnosis and management (NICE clinical guideline 147) PB - National Institute of Clinical Excellence CY - London ID - ref46 ER - TY - BOOK PY - 2011 DA - 2011// TI - Management of stable angina (NICE clinical guideline 126) PB - National Institute of Clinical Excellence CY - London ID - ref47 ER - TY - STD TI - NICE: Technology Appraisal Guidance 85: Immunosuppressive therapy for renal transplantation in adults. Reviewed August 2007 edition. pp. 45. London: National Institute for Clinical Excellence; September 2004:45. ID - ref48 ER - TY - BOOK AU - Brazier, J. R. AU - Ratcliffe, J. AU - Salomon, J. A. AU - Tsuchiya, A. PY - 2007 DA - 2007// TI - Measuring and Valuing Health benefits for Economic Evaluation. In PB - Oxford University Press CY - New York ID - Brazier2007 ER - TY - JOUR AU - Belozeroff, V. AU - Cooper, K. AU - Hess, G. AU - Chang, C. L. PY - 2013 DA - 2013// TI - Healthcare use and costs before and after parathyroidectomy in patients on dialysis JO - BMC Health Serv Res VL - 13 UR - https://doi.org/10.1186/1472-6963-13-248 DO - 10.1186/1472-6963-13-248 ID - Belozeroff2013 ER - TY - JOUR AU - Lafrance, J. P. AU - Cardinal, H. AU - Leblanc, M. AU - Madore, F. AU - Pichette, V. AU - Roy, L. PY - 2013 DA - 2013// TI - Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends JO - BMC Nephrol VL - 14 UR - https://doi.org/10.1186/1471-2369-14-100 DO - 10.1186/1471-2369-14-100 ID - Lafrance2013 ER - TY - JOUR AU - Li, S. AU - Chen, Y. W. AU - Peng, Y. AU - Foley, R. N. AU - St Peter, W. L. PY - 2011 DA - 2011// TI - Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007 JO - Am J Kidney Dis VL - 57 UR - https://doi.org/10.1053/j.ajkd.2010.10.041 DO - 10.1053/j.ajkd.2010.10.041 ID - Li2011 ER - TY - JOUR AU - Brazier, J. PY - 2008 DA - 2008// TI - Valuing health States for use in cost-effectiveness analysis JO - Pharmacoeconomics VL - 26 UR - https://doi.org/10.2165/00019053-200826090-00007 DO - 10.2165/00019053-200826090-00007 ID - Brazier2008 ER - TY - BOOK PY - 2006 DA - 2006// TI - Guidelines for the economic evaluation of health technologies PB - Ottawa: Canadian Agency for Drugs and Technologies in Health CY - Canada ID - ref54 ER - TY - BOOK PY - 2013 DA - 2013// TI - Process and methods guides PB - National Institute for Health and Clinical Excellence CY - London, UK ID - ref55 ER - TY - STD TI - PBAC (Pharmaceutical Benefits Advisory Committee): Guidelines for preparing submissions to PBAC, Version 4.3.2. PBAC; 2008. ID - ref56 ER - TY - JOUR AU - Dolan, P. AU - Gudex, C. AU - Kind, P. AU - Williams, A. PY - 1996 DA - 1996// TI - The time trade-off method: results from a general population study JO - Health Econ VL - 5 UR - https://doi.org/3.0.CO;2-N DO - 3.0.CO;2-N ID - Dolan1996 ER - TY - JOUR AU - Smith, D. W. AU - Davies, E. W. AU - Wissinger, E. AU - Huelin, R. AU - Matza, L. S. AU - Chung, K. PY - 2013 DA - 2013// TI - A systematic literature review of cardiovascular event utilities JO - Expert Rev Pharmacoecon Outcomes Res VL - 13 UR - https://doi.org/10.1586/14737167.2013.841545 DO - 10.1586/14737167.2013.841545 ID - Smith2013 ER - TY - JOUR AU - Arnesen, T. AU - Trommald, M. PY - 2005 DA - 2005// TI - Are QALYs based on time trade-off comparable?–a systematic review of TTO methodologies JO - Health Econ VL - 14 UR - https://doi.org/10.1002/hec.895 DO - 10.1002/hec.895 ID - Arnesen2005 ER - TY - JOUR AU - Hamel, M. B. AU - Phillips, R. S. AU - Davis, R. B. AU - Desbiens, N. AU - Connors, A. F. AU - Teno, J. M. PY - 1997 DA - 1997// TI - Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT investigators. Study to understand prognoses and preferences for outcomes and risks of treatments JO - Ann Intern Med VL - 127 UR - https://doi.org/10.7326/0003-4819-127-3-199708010-00003 DO - 10.7326/0003-4819-127-3-199708010-00003 ID - Hamel1997 ER - TY - JOUR AU - Hurny, C. AU - Wegberg, B. AU - Bacchi, M. AU - Bernhard, J. AU - Thurlimann, B. AU - Real, O. PY - 1998 DA - 1998// TI - Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials JO - Br J Cancer VL - 77 UR - https://doi.org/10.1038/bjc.1998.162 DO - 10.1038/bjc.1998.162 ID - Hurny1998 ER - TY - JOUR AU - Matza, L. S. AU - Chung, K. AU - Brunt, K. AU - Brazier, J. E. AU - Braun, A. AU - Currie, B. PY - 2014 DA - 2014// TI - Health state utilities for skeletal-related events secondary to bone metastases JO - Eur J Health Econ VL - 15 UR - https://doi.org/10.1007/s10198-012-0443-2 DO - 10.1007/s10198-012-0443-2 ID - Matza2014 ER - TY - JOUR AU - Matza, L. S. AU - Cong, Z. AU - Chung, K. AU - Stopeck, A. AU - Tonkin, K. AU - Brown, J. PY - 2013 DA - 2013// TI - Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases JO - Patient Prefer Adherence VL - 7 UR - https://doi.org/10.2147/PPA.S44947 DO - 10.2147/PPA.S44947 ID - Matza2013 ER - TY - JOUR AU - O'Leary, J. F. AU - Fairclough, D. L. AU - Jankowski, M. K. AU - Weeks, J. C. PY - 1995 DA - 1995// TI - Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship JO - Med Decis Making VL - 15 UR - https://doi.org/10.1177/0272989X9501500205 DO - 10.1177/0272989X9501500205 ID - O'Leary1995 ER - TY - JOUR AU - Schulz, M. W. AU - Chen, J. AU - Woo, H. H. AU - Keech, M. AU - Watson, M. E. AU - Davey, P. J. PY - 2002 DA - 2002// TI - A comparison of techniques for eliciting patient preferences in patients with benign prostatic hyperplasia JO - J Urol VL - 168 UR - https://doi.org/10.1016/S0022-5347(05)64851-3 DO - 10.1016/S0022-5347(05)64851-3 ID - Schulz2002 ER - TY - JOUR AU - Stevenson, L. W. AU - Hellkamp, A. S. AU - Leier, C. V. AU - Sopko, G. AU - Koelling, T. AU - Warnica, J. W. PY - 2008 DA - 2008// TI - Changing preferences for survival after hospitalization with advanced heart failure JO - J Am Coll Cardiol VL - 52 UR - https://doi.org/10.1016/j.jacc.2008.08.028 DO - 10.1016/j.jacc.2008.08.028 ID - Stevenson2008 ER - TY - JOUR AU - Tsevat, J. AU - Cook, E. F. AU - Green, M. L. AU - Matchar, D. B. AU - Dawson, N. V. AU - Broste, S. K. PY - 1995 DA - 1995// TI - Health values of the seriously ill support investigators JO - Ann Intern Med VL - 122 UR - https://doi.org/10.7326/0003-4819-122-7-199504010-00007 DO - 10.7326/0003-4819-122-7-199504010-00007 ID - Tsevat1995 ER - TY - JOUR AU - Tsevat, J. AU - Dawson, N. V. AU - Wu, A. W. AU - Lynn, J. AU - Soukup, J. R. AU - Cook, E. F. PY - 1998 DA - 1998// TI - Health values of hospitalized patients 80 years or older HELP investigators hospitalized elderly longitudinal project JO - JAMA VL - 279 UR - https://doi.org/10.1001/jama.279.5.371 DO - 10.1001/jama.279.5.371 ID - Tsevat1998 ER - TY - JOUR AU - Gerard, K. AU - Dobson, M. AU - Hall, J. PY - 1993 DA - 1993// TI - Framing and labelling effects in health descriptions: quality adjusted life years for treatment of breast cancer JO - J Clin Epidemiol VL - 46 UR - https://doi.org/10.1016/0895-4356(93)90011-O DO - 10.1016/0895-4356(93)90011-O ID - Gerard1993 ER - TY - JOUR AU - Rowen, D. AU - Brazier, J. AU - Tsuchiya, A. AU - Young, T. AU - Ibbotson, R. PY - 2012 DA - 2012// TI - It's all in the name, or is it? The impact of labeling on health state values JO - Med Decis Making VL - 32 UR - https://doi.org/10.1177/0272989X11408435 DO - 10.1177/0272989X11408435 ID - Rowen2012 ER - TY - JOUR AU - Sackett, D. L. AU - Torrance, G. W. PY - 1978 DA - 1978// TI - The utility of different health states as perceived by the general public JO - J Chronic Dis VL - 31 UR - https://doi.org/10.1016/0021-9681(78)90072-3 DO - 10.1016/0021-9681(78)90072-3 ID - Sackett1978 ER -